Saquinavir

Drug Profile

Saquinavir

Alternative Names: Fortovase; Invirase; RO 318959; RO 318959/003

Latest Information Update: 30 Oct 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Roche
  • Class Antiretrovirals; Isoquinolines; Quinolines
  • Mechanism of Action HIV protease inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed HIV infections

Most Recent Events

  • 18 Jul 2016 Biomarkers information updated
  • 26 Oct 2007 Final results from a phase IIIb clinical trial (Gemini) added to the adverse events and Viral Infections pharmacodynamics and therapeutic trials sections
  • 15 Nov 2006 Interim 24-week results from a phase IIIb clinical trial (Gemini study) in treatment-naive patients with HIV infections have been added to the adverse events and Viral infections therapeutic trials sections
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top